Schedule 13G ownership disclosure

Adamis Pharmaceuticals Corp

Security class unavailable · CUSIP: 00547W208

Event date: 2016-08-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
969,300
Percent of class
4.6400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-16-000160
Form type
SC 13G
Filer
DMK PHARMACEUTICALS Corp
CIK
CIK 887247
Filed
Aug 09, 2016
Reporting period
Aug 03, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub